Handa Y - Search Results

1

Postoperative Pulmonary Function After Complex Segmentectomy.

Handa Y, Tsutani Y, Mimae T, Miyata Y, Okada M. Handa Y, et al. Ann Surg Oncol. 2021 Dec;28(13):8347-8355. doi: 10.1245/s10434-021-09828-9. Epub 2021 Jul 22. Ann Surg Oncol. 2021. PMID: 34296359

2

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer.

Handa Y, Tsutani Y, Tsubokawa N, Misumi K, Hanaki H, Miyata Y, Okada M. Handa Y, et al. Ann Thorac Surg. 2017 Dec;104(6):1896-1901. doi: 10.1016/j.athoracsur.2017.06.060. Epub 2017 Oct 21. Ann Thorac Surg. 2017. PMID: 29033013

3

Reassessment of Right Middle Lobe Lung Cancer: Comparison of Segments 4 and 5 Tumors.

Handa Y, Tsutani Y, Ikeda T, Hanaki H, Miyata Y, Mukaida H, Okada M. Handa Y, et al. Ann Thorac Surg. 2018 May;105(5):1543-1550. doi: 10.1016/j.athoracsur.2017.12.007. Epub 2018 Jan 9. Ann Thorac Surg. 2018. PMID: 29329989

4

Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer.

Tsubokawa N, Tsutani Y, Miyata Y, Handa Y, Misumi K, Hanaki H, Hida E, Okada M. Tsubokawa N, et al. Among authors: handa y. World J Surg. 2018 Aug;42(8):2493-2501. doi: 10.1007/s00268-018-4514-0. World J Surg. 2018. PMID: 29423740

5

Surgical Outcomes of Complex Versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer.

Handa Y, Tsutani Y, Mimae T, Tasaki T, Miyata Y, Okada M. Handa Y, et al. Ann Thorac Surg. 2019 Apr;107(4):1032-1039. doi: 10.1016/j.athoracsur.2018.11.018. Epub 2018 Dec 11. Ann Thorac Surg. 2019. PMID: 30550801

6

Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer.

Handa Y, Tsutani Y, Mimae T, Miyata Y, Okada M. Handa Y, et al. Eur J Cardiothorac Surg. 2020 Jan 1;57(1):114-121. doi: 10.1093/ejcts/ezz185. Eur J Cardiothorac Surg. 2020. PMID: 31230086

7

Reply to Li and Che.

Handa Y, Tsutani Y, Okada M. Handa Y, et al. Eur J Cardiothorac Surg. 2020 Mar 1;57(3):614-615. doi: 10.1093/ejcts/ezz232. Eur J Cardiothorac Surg. 2020. PMID: 31504384 No abstract available.

8

Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.

Tsutani Y, Kagimoto A, Handa Y, Mimae T, Miyata Y, Okada M. Tsutani Y, et al. Among authors: handa y. Jpn J Clin Oncol. 2019 Dec 27;49(12):1134-1142. doi: 10.1093/jjco/hyz122. Jpn J Clin Oncol. 2019. PMID: 31602468

9

Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component.

Kishi N, Ito M, Miyata Y, Kanai A, Handa Y, Tsutani Y, Kushitani K, Takeshima Y, Okada M. Kishi N, et al. Among authors: handa y. Ann Surg Oncol. 2020 Mar;27(3):945-955. doi: 10.1245/s10434-019-07854-2. Epub 2019 Nov 15. Ann Surg Oncol. 2020. PMID: 31732945

10

Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.

Handa Y, Tsutani Y, Shiroma N, Kai Y, Mimae T, Miyata Y, Takeshima Y, Arihiro K, Okada M. Handa Y, et al. Clin Lung Cancer. 2020 Jul;21(4):e302-e314. doi: 10.1016/j.cllc.2020.01.013. Epub 2020 Jan 27. Clin Lung Cancer. 2020. PMID: 32102750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters